Login to Your Account

Astrazeneca, GSK mine academia in separate deals to stoke pipelines

By Nuala Moran
Staff Writer

Monday, March 31, 2014
LONDON – Astrazeneca plc and Glaxosmithkline (GSK) plc are both forming partnerships with publicly funded research bodies to set up new centers for early stage drug research in Cambridge.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription